162 related articles for article (PubMed ID: 3729947)
1. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
Uitendaal MP; Thijssen HH; Drittij-Reijnders MJ; Hoeijmakers MJ
Biochem Biophys Res Commun; 1986 Jun; 137(3):1015-20. PubMed ID: 3729947
[TBL] [Abstract][Full Text] [Related]
2. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
[TBL] [Abstract][Full Text] [Related]
3. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
Cain D; Hutson SM; Wallin R
J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
[TBL] [Abstract][Full Text] [Related]
4. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
Thijssen HH; Janssen YP; Vervoort LT
Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
[TBL] [Abstract][Full Text] [Related]
5. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
Fasco MJ; Principe LM; Walsh WA; Friedman PA
Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
[TBL] [Abstract][Full Text] [Related]
6. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
Lee JJ; Principe LM; Fasco MJ
Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
[TBL] [Abstract][Full Text] [Related]
7. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
Fasco MJ; Hildebrandt EF; Suttie JW
J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
[TBL] [Abstract][Full Text] [Related]
8. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
Mukharji I; Silverman RB
Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
Thijssen HH; Drittij-Reijnders MJ
Br J Haematol; 1993 Aug; 84(4):681-5. PubMed ID: 8217828
[TBL] [Abstract][Full Text] [Related]
10. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
Guenthner TM; Cai D; Wallin R
Biochem Pharmacol; 1998 Jan; 55(2):169-75. PubMed ID: 9448739
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
Creedon KA; Suttie JW
Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system.
Fasco MJ; Principe LM
Biochem Biophys Res Commun; 1980 Dec; 97(4):1487-92. PubMed ID: 7213374
[No Abstract] [Full Text] [Related]
13. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
Wallin R; Martin LF
J Clin Invest; 1985 Nov; 76(5):1879-84. PubMed ID: 3932474
[TBL] [Abstract][Full Text] [Related]
14. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
Preusch PC; Suttie JW
J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
[TBL] [Abstract][Full Text] [Related]
15. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
[TBL] [Abstract][Full Text] [Related]
16. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
Fasco MJ; Principe LM
J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
[TBL] [Abstract][Full Text] [Related]
17. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
[TBL] [Abstract][Full Text] [Related]
18. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver.
Begent LA; Hill AP; Steventon GB; Hutt AJ; Pallister CJ; Cowell DC
J Pharm Pharmacol; 2001 Apr; 53(4):481-6. PubMed ID: 11341364
[TBL] [Abstract][Full Text] [Related]
19. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
Thijssen HH; Baars LG
Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
[TBL] [Abstract][Full Text] [Related]
20. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
Preusch PC; Suttie JW
Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]